Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2020 Oct 29;13(10):e235662. doi: 10.1136/bcr-2020-235662

Reappraisal of haemorrhagic suprasellar pilocytic astrocytoma during adulthood

Gustavo M Cortez 1,2, Andre Monteiro 1, Benjamin Ludwig 1, Ricardo Hanel 1,
PMCID: PMC7597472  PMID: 33122224

Abstract

Pilocytic astrocytomas comprise the most common central nervous system tumour during childhood and have an excellent response to surgical treatment in this population. The tumour incidence decreases with age, whereas more aggressive behaviour tends to increase. Haemorrhage as a presenting feature of pilocytic astrocytomas is a rare phenomenon, especially in the adult population. We present a case of a 55-year-old patient with progressive headaches and dizziness. MRI confirmed a sellar and predominantly retrochiasmal suprasellar lesion with heterogeneous signal, enhancement and blood products. Management via transsphenoidal approach was performed, and histopathology revealed the unexpected diagnosis of haemorrhagic pilocytic astrocytoma. Haemorrhagic pilocytic astrocytoma is an infrequent entity in the adult population and it is essential to recognise the peculiarities regarding diagnostic evaluation and management, which differ from the paediatric population. During adulthood, this tumour carries an overall unfavourable prognosis, with higher rates of progression and recurrence.

Keywords: neurosurgery, CNS cancer, neurooncology, neuroimaging, neuroendocrinology

Background

Pilocytic astrocytomas (PAs) are the most common primary central nervous system tumour during childhood, with a mean age at diagnosis varying between 6.8 and 7.7 years old. They tend to have an indolent progression and a thriving treatment response to surgical resection.1 2 The presentation of this subtype of astrocytoma, however, is not common later in life, with a decrease in incidence with age.3 Adding tumour-associated bleeding to the equation restricts the number of cases described in the literature.4

We describe a distinct case of a man on his fifties who presented with a suprasellar mass and underwent transsphenoidal resection. Histopathology revealed the unexpected diagnosis of a suprasellar haemorrhagic PA. An overview of the literature is discussed.

Case presentation

A 55-year-old man presented to an outside hospital complaining of progressively worsening headaches and dizziness for the past 6 weeks. The headaches would worsen when standing or looking up to the ceiling. He also had occasional episodes of blurry vision with spontaneous resolution, but denied issues with his peripheral vision. On review of the systems, there were no complaints of weakness, paresthesia, excessive thirst or polyuria. The remainder of the neurological examination was normal. Medical history was relevant for uncontrolled hypertension due to long-term non-compliance with prescribed medication.

Investigations

Initial head non-contrast CT, performed in the emergency department, demonstrated a heterogeneously attenuating, partially haemorrhagic suprasellar lesion. It measured approximately 2.6×1.7×1.3 cm and concomitant hydrocephalus was noted, most likely related to mass effect (figure 1). No expansion or remodelling of the bony sella was identified. CT angiography of the head revealed mild local mass effect on the circle of Willis structures, but no associated vascular abnormality. Chest X-ray and initial basic laboratory evaluation were unremarkable.

Figure 1.

Figure 1

Axial (A), sagittal (B), and coronal (C) non-contrast CT head images demonstrate a heterogeneously attenuating sellar and suprasellar lesion with hyperdensity centrally, presumed to reflect intratumoural haemorrhage. Note dilatation of the lateral ventricular temporal horns bilaterally, consistent with hydrocephalus.

The patient was transferred to our hospital for further clinical evaluation by neurosurgery and endocrinology. MRI demonstrated a sellar and predominantly retrochiasmal suprasellar lesion with heterogeneous signal, enhancement and blood products (figure 2). The possibility of normal pituitary tissue along the sellar floor was raised. Findings favoured craniopharyngioma rather than pituitary adenoma as possible diagnoses. Neurological examination remained unchanged, with fluctuating headache from mild to none. He had also started on corticosteroids, secondary to optic chiasm impingement.

Figure 2.

Figure 2

Non-contrast coronal T2 sequence demonstrates the sellar and suprasellar lesion with central T2 hypointense signal, correlating with blood products and peripheral T2 hyperintense signal (A). Precontrast sagittal T1 sequence demonstrates a lobulated sellar and retrochiasmal suprasellar lesion with heterogeneous T1 signal (B). Postcontrast depicts enhancing pituitary tissue displaced along the floor of the sella turcica, with heterogeneous enhancement throughout the lesion (C).

Detailed preoperative laboratory evaluation showed mild low testosterone (233.4 ng/dL), low Follicle-Stimulating Hormone (3.9 mIU/mL), and low Luteinizing Hormone (2.7 mIU/mL) suggestive of secondary hypogonadism. Decreased cortisol (3.7 μg/dL) and Adrenocorticotropic Hormone (<5 pg/mL) levels were present, which was assumed to result from dexamethasone use before labs were drawn. Prolactin (12.9 ng/mL), testosterone (233.4 ng/dL), Thyroid-Stimulating Hormone (1.57 μIU/ml), free T4 (0.9 ng/dL), Human Growth Hormone (0.52 ng/dL) and Insulin-like Growth Factor-1 (233 ng/dL) were unremarkable. A non-functional mass was, therefore, favoured.

Treatment

Given the history of progressive headaches, endocrine and radiological findings, surgery was considered and discussed with the patient. Because the lesion was sited at midline and there was no major involvement of adjacent structures, we opted for a transsphenoidal approach of the lesion. A preoperative lumbar spinal drain was placed. Endoscopic endonasal access was performed after extensive drilling of the sella, to gain access to suprasellar and retrosellar compartments. After dural incision and access to the tumour, the pathology sample was undertaken and sent to analysis, while we proceeded with tumour excision. Preliminary frozen intraoperative report favoured astrocytoma rather than craniopharyngioma. In either case, we decided that total resection was the best aim. After excision of the tumour, a cerebrospinal fluid (CSF) leakage became evident and was managed by multilayer closure involving a nasoseptal flap. No major intraprocedural complications were identified.

Outcome and follow-up

Pathology demonstrated glial neoplasm with Rosenthal fibres and eosinophilic granular bodies (figure 3). The tumour was composed of monotonous spindle cells and round oligodendrocyte-like cells within microcystic areas. Hyalinised blood vessels and fragments of organising thrombus were present. There was no evidence of necrosis. Immunohistochemical stains for Glial Fibrillary Acidic Protein (GFAP), synaptophysin and S100 were positive. Neurofilament demonstrated staining at the periphery of two fragments. Isocitrate dehydrogenase-1 (IDH-1) R132H was negative and ATRX showed intact nuclear staining by immunohistochemistry. Mitotic figures were inconspicuous, and the Ki-67 proliferation index was low. The findings were consistent with a suprasellar PA, WHO grade I. Molecular studies for BRAF gene rearrangement, and BRAF mutations were negative.

Figure 3.

Figure 3

H&E-stained sections show a biphasic tumour with mildly cellular areas comprised of piloid cells and hyalinised blood vessels (A) and areas with oligodendrocyte-like cells containing microcysts and eosinophilic granular bodies (B). Focally, Rosenthal fibres are frequent (C). The tumour is diffusely GFAP positive (D) and has only focal neurofilament staining (E). The Ki-67 proliferation index is low (F).

Postoperative course was complicated by right hemiparesis, with subsequent dysphagia and urinary retention. The patient also experienced acute encephalopathy, persistent hydrocephalus and adrenal insufficiency, which were successfully managed. A postoperative MRI revealed anterior left thalamic acute infarction and debulking of the previously identified suprasellar mass. There was a thin peripheral rim of enhancement along the anterior margin of the suprasellar resection cavity, which was also present on the preoperative MRI and could reflect a small volume of residual tumour (figure 4). The patient was discharged for rehabilitation with a remnant right hemiparesis, but an improvement of his dysphagia was noted.

Figure 4.

Figure 4

Immediate postoperative axial MR images demonstrate thin peripheral rim of enhancement along the anterior margin of the suprasellar resection cavity on T1-weighted (A) and acute anterior infarct of let thalamus on DWI (B). Three weeks follow-up, confirming large debulking on sagittal flair T1-weight images (C).

Discussion

We report a case of a patient with progressive headache and essentially unremarkable medical history. Imaging studies revealed a haemorrhagic suprasellar mass, and initial differential diagnosis was craniopharyngioma. The patient underwent a transsphenoidal approach, and histopathology returned the unexpected diagnosis of PA.

PAs are benign WHO grade 1 neoplasm, with an annual incidence during childhood varying from 4.2 to 8.4 for every hundred thousand patients.2 In this population, this tumour accounts for approximately 18% of all primary brain tumours and are most commonly located in the cerebellum. They have an overall good prognosis, with a 10-year survival rate over 90%.1 2 It is distinctly uncommon for PA to present in the late decades of life.5 The average age of presentation in adults is 32.2 (SD 9.4), with a progressive decrease in incidence with age.3 4 In contrast to the paediatric population, the 5-year survival rate goes from 89.9% in patients>20 years old to 59.6% in patients older than 60, with age significantly associated with hazard of death in univariate analysis (HR 1.5, 95% CI 1.4 to 1.6, for each 10 years of age).3 During adulthood, PAs are predominantly extracerebellar, with the most substantial proportion located supratentorially. They carry an overall poor prognosis, with associated increased rates of recurrence, progression, malignant transformation and leptomeningeal dissemination.6 In particular, leptomeningeal seeding is commonly associated with a primary lesion located near a CSF space, mainly when situated in the sellar region. Additionally, surgical manipulation, haemorrhage and features of anaplasia are also considered risk factors for leptomeningeal dissemination.7 8

Tumour-associated haemorrhage is scarcely seen in low-grade astrocytomas, rendering it challenging to determine how it might influence patient outcomes. It was postulated that bleeding risk in this subset of low-grade tumours might be related to an abnormal vasculature within the tumour and local metabolic factors.9 The exact bleeding risk cannot be inferred with the available literature. However, the risk for a haemorrhagic transformation seems to be equal between the paediatric and adult populations (ratio 1.1:1).10 In a review of radiologic aspects, Kikuchi et al described a 10% prevalence of intratumoural haemorrhage in PAs and suggested perfusion dynamic susceptibility MRI cut-off values that would corroborate in the differentiation of PA from high-grade glial tumours.11 Using an ROC-AUC analysis, they found that optimal diagnostic cut-off values of ≤1.08 for regional cerebral blood flow (rCBFmax), ≤4.08 for relative cerebral blood volume (rCBVmax), and ≥1.38 x 10–3 mm2/s for apparent diffusion coefficient (ADCmin) would favour a PA diagnosis. Rather haemorrhagic or not, PA may occupy the suprasellar region when they arise from the pituitary gland or when they arise from adjacent structures and invade it by extension.12 The overall prevalence in this region range from 7% to 17% in the adult population.4 13 Not many cases have been reported in which the origin of the tumour was proven to be from the pituitary gland itself. Parish et al reported two of these cases, which were managed with a transsphenoidal approach.12 They were complicated by a CSF leaking, a recognised possible complication of this approach, but that can be avoided with the suitable use of a pedicled nasoseptal flap, as in our case.

Radiological features are paramount for diagnostic evaluation and treatment planning. From this standpoint, different factors have to be considered, such as the epicentre of the lesion, detailed imaging characteristics (including solid, cystic or mixed components), presence of sellar remodelling, calcification, haemorrhage, vascular features and enhancement characteristics. In an adult with a heterogeneous sellar or suprasellar multilobulated lesion felt to arise separately from the pituitary gland, the primary differential diagnosis favours craniopharyngioma.14 The papillary subtype presents with solid and enhancing components, commonly seen in the fifth and sixth decade of life; differing from adamantinomatous subtype, which is seen earlier in life. Given our patient demographics, imaging features and difficulty in determining the exact origin of the lesion, additional differential diagnosis was a macroadenoma, as well as less common entities like pituicytoma and granular cell tumour.15 16 PAs commonly present radiologically as a cystic mass with characteristic postcontrast enhancement.5 In low-grade astrocytomas, local oedema is not a common finding but may become prominent in the occurrence of haemorrhagic transformation.17 Imaging findings require from upfront a high level of suspicion given their most non-specific findings and variable baseline characteristics of these patients. Radiological features are reviewed in table 1.

Table 1.

Suprasellar pilocytic astrocytoma—radiological features and differential diagnosis

Pilocytic astrocytoma Craniopharyngioma Macroadenoma
Location Intra-axial Extra-axial, separate from pituitary; rarely intrasellar Extra-axial, arises from pituitary
Calcification Uncommon Adamantinomatous →common (90%) Uncommon
Papillary → rare
Haemorrhage Rare Adamantinomatous → rare, high density is typically related to proteinaceous contents Macroadenoma –10%, also in the setting of apoplexy
Papillary → rare
Enhancement Variable enhancement Adamantinomatous → Enhancement of cyst wall and solid components Strong, can be heterogeneous
Papillary → solid enhancement
Sellar expansion/bone remodeling Absent Absent Can be present
Composition Solid, cyst with mural nodule Adamantinomatous → Mixed solid and cystic (90%) Solid, but can have cysts/necrosis
Papillary → Typically solid
Age 5–15 years Adamantinomatous → 5–15 and 40–60 years (bimodal) Peak 20–40 years
Papillary → 40-60 years

Until a few years ago, every astrocytic tumour that presumably arises from the posterior pituitary was considered a pituicytoma, and the terms were used interchangeably.18–20 Notwithstanding, more recent pathological studies showed that, although they share similarities, pituicytomas lack Rosenthal fibres, eosinophilic granular bodies, and other distinctive characteristics commonly seen on astrocytomas.15 Attempts have been made to distinguish the two entities via imaging, with a tendency for a faster enhancement after injection of contrast and a tail of enhancement to the pituitary stalk described with pituicytomas.18 19 Practically, the lesions are very difficult to differentiate through imaging. Other common differential diagnoses, such as craniopharyngioma and suprasellar PA, may also be indistinguishable on imaging.14

Both craniopharyngioma and PA have surgical resection as first-line treatment, with surgery frequently performed with diagnostic and therapeutic intent. Gross total resection is the only treatment with evidence of improving survival in newly diagnosed adults’ patients.6 In this age group, adjuvant radiotherapy may be considered when the lesion is not amenable to complete resection.21 Radiation therapy, however, was not found to impact overall survival, and there may be an association with an increased risk for malignant transformation.3 22 23 The exact radiation technique also interferes with the potential benefits and risks.24 25

To the best of our knowledge, seven cases of haemorrhagic PA after the fifth decade of life had been described in the literature (table 2), but only one of them was in the suprasellar region.9 17 26–30 The patient similarly presented with a history of headache and visual disturbances, arriving obtunded on the emergency department.28 CT was performed addressing a hyperdense suprasellar mass and hydrocephalus, as in our patient. He underwent craniotomy with subtotal resection of the lesion. We, conversely, opted for a transsphenoidal approach in our patient once the suprasellar lesion was sitting at midline and there was no major involvement of adjacent structures. Injury to thalamic perforator vessels, a complex and variable irrigation system, may explain the postoperative right-sided hemiparesis.31 Overall, though, transsphenoidal and transcranial approaches demonstrated similar safety profiles and rates of total gross resection, which may vary according to the exact type of tumour.32 33 Although some may argue that an initial craniotomy approach, instead of transsphenoidal, could have allowed total resection and avoided the ischaemic complication, there is no robust data that supports these statements. According to the National Surgical Quality Improvement Program, postoperative complications occurred in one-third of patients undergoing craniotomy for craniopharyngioma resection.34 Jeswani et al found similar surgical outcomes between the groups, except that more CSF leak was seen in the transsphenoidal group, whereas more neurological injuries occurred in the craniotomy group.35 Also analysing patients with craniopharyngiomas, a meta-analyse by Komotar et al elucidated a higher rate of total resection in patients who underwent a transsphenoidal approach (p=<0.003), with no differences in the rate of stroke between the groups.36 Wannemuehler et al also described similar surgical outcomes between the two approaches.37 Additionally, rates of recurrence tend to be lower with tumours managed via transsphenoidal approach.32 33 There is a paucity of data regarding surgical approach to suprasellar PA, therefore, the decision for the approach must aim for lower morbidity risk and must be evaluated on a case-by-case basis.

Table 2.

Haemorrhagic pilocytic astrocytoma in patients older than 50 years old

Author Year Age/sex Clinical presentation Location Treatment Comments
Lones30 1991 69/F Left side weakness Cerebral hemisphere N/A Acute IVH and death before any intervention
Sorenson26 1995 58/F Transient amnesia Hypothalamic OB Memory impairment following biopsy
Lyons27 2007 75/M Aphasia Temporal region GTR Two previous episodes of
ICH associated with warfarin
White9 2008 58/F Headache and ataxia Pons GTR
Sekula28 2008 65/M Headache and visual changes Suprasellar STR
Kim17 2011 53/M Headache Cerebellum GTR
Sun29 2018 62/M Headache and ataxia Cerebellum GTR

F, female; GTR, gross total resection; ICH, intracranial haemorrhage; IVH, intraventricular haemorrhage; M, male; N/A, not applicable; OB, open biopsy; STR, subtotal resection.

There are three essential features of our PA case that make it special: patient age, tumour location, and concomitant haemorrhage. Association between an aggressive phenotype and adult age group can be found in PAs, with survival rate in the adult group found to be negatively correlated to age, tumour size and treatment with radiotherapy.3 Given the higher incidence of leptomeningeal dissemination originally from the sellar region, it is also important to evaluate for leptomeningeal disease. We hope that our presented case and review can help clarify some distinctive features of suprasellar haemorrhagic PAs and bring awareness of this pathology in the adult population. In order to contribute to the best of patient care, this subset of tumour has to be part of the differential diagnosis of a haemorrhagic suprasellar mass.

Learning points.

  • Pilocytic astrocytomas have an overall benign course during childhood but may acquire an aggressive behaviour with age.

  • Tumour-associated haemorrhage is not commonly seen in low-grade gliomas, and careful imaging evaluation must be warranted.

  • When located in the suprasellar region, adult pilocytic astrocytomas have a most indistinguishable clinical and radiological presentation from other suprasselar tumours. Tumour in this location has also been associated with increased risk for leptomeningeal dissemination.

Footnotes

Contributors: GC: substantial contributions to the conceptualisation of the work, data acquisition and interpretation; drafting and revision of the work. AM: substantial contributions to the conceptualisation of the work, data acquisition and interpretation. BL: substantial contributions to the conceptualisation and design of the work. RH: original idea, data supervision and interpretation; revision of the work, approval of the final version; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: RH, senior author of the above-mentioned manuscript, is consultant for Covidien, Stryker, Codman and MicroVention.

Patient consent for publication: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Burkhard C, Di Patre P-L, Schüler D, et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 2003;98:1170–4. 10.3171/jns.2003.98.6.1170 [DOI] [PubMed] [Google Scholar]
  • 2.Georgakis MK, Karalexi MA, Kalogirou EI, et al. Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and seer, us. J Neurooncol 2017;131:163–75. 10.1007/s11060-016-2284-9 [DOI] [PubMed] [Google Scholar]
  • 3.Johnson DR, Brown PD, Galanis E, et al. Pilocytic astrocytoma survival in adults: analysis of the surveillance, epidemiology, and end results program of the National cancer Institute. J Neurooncol 2012;108:187–93. 10.1007/s11060-012-0829-0 [DOI] [PubMed] [Google Scholar]
  • 4.Bond KM, Hughes JD, Porter AL, et al. Adult pilocytic astrocytoma: an institutional series and systematic literature review for extent of resection and recurrence. World Neurosurg 2018;110:276–83. 10.1016/j.wneu.2017.11.102 [DOI] [PubMed] [Google Scholar]
  • 5.Koeller KK, Rushing EJ. From the Archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 2004;24:1693–708. 10.1148/rg.246045146 [DOI] [PubMed] [Google Scholar]
  • 6.Stüer C, Vilz B, Majores M, et al. Frequent recurrence and progression in pilocytic astrocytoma in adults. Cancer 2007;110:2799–808. 10.1002/cncr.23148 [DOI] [PubMed] [Google Scholar]
  • 7.Soliman RK, Budai C, Mundada P, et al. Suprasellar pilocytic astrocytoma in an adult with hemorrhage and leptomeningeal dissemination: case report and review of literature. Radiol Case Rep 2016;11:411–8. 10.1016/j.radcr.2016.08.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.McBride D, Aljuboori Z, Hattab EM, et al. An elderly patient presenting with a primary spinal multifocal intradural extramedullary pilocytic astrocytoma: a case report and review of the literature. BMC Cancer 2018;18:806. 10.1186/s12885-018-4721-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.White JB, Piepgras DG, Scheithauer BW, et al. Rate of spontaneous hemorrhage in histologically proven cases of pilocytic astrocytoma. J Neurosurg 2008;108:223–6. 10.3171/JNS/2008/108/2/0223 [DOI] [PubMed] [Google Scholar]
  • 10.Prasad GL, Nandeesh BN, Menon GR. Hemorrhagic presentation of intracranial pilocytic astrocytomas: literature review. Neurosurg Rev 2019;42:97–106. 10.1007/s10143-017-0915-z [DOI] [PubMed] [Google Scholar]
  • 11.Kikuchi K, Hiwatashi A, Togao O, et al. Usefulness of perfusion- and diffusion-weighted imaging to differentiate between pilocytic astrocytomas and high-grade gliomas: a multicenter study in Japan. Neuroradiology 2018;60:391–401. 10.1007/s00234-018-1991-7 [DOI] [PubMed] [Google Scholar]
  • 12.Parish JM, Bonnin JM, Payner TD, et al. Intrasellar pilocytic astrocytomas: clinical, imaging, pathological, and surgical findings. J Clin Neurosci 2015;22:653–8. 10.1016/j.jocn.2014.10.010 [DOI] [PubMed] [Google Scholar]
  • 13.Theeler BJ, Ellezam B, Sadighi ZS, et al. Adult pilocytic astrocytomas: clinical features and molecular analysis. Neuro Oncol 2014;16:841–7. 10.1093/neuonc/not246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Skipworth JRA, Hill CS, Jones T, et al. Pilocytic astrocytoma mimicking craniopharyngioma: a case series. Ann R Coll Surg Engl 2012;94:e125–8. 10.1308/003588412X13171221588811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Brat DJ, Scheithauer BW, Fuller GN, et al. Newly codified glial neoplasms of the 2007 who classification of tumours of the central nervous system: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 2007;17:319–24. 10.1111/j.1750-3639.2007.00082.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Borg MA, Jaunmuktane DZ, Dorward MN. Tumours of the Neurohypophysis - One unit’s experience and literature review. World Neurosurg 2019. [DOI] [PubMed] [Google Scholar]
  • 17.Kim M-S, Kim SW, Chang C-H, et al. Cerebellar pilocytic astrocytomas with spontaneous intratumoral hemorrhage in adult. J Korean Neurosurg Soc 2011;49:363–6. 10.3340/jkns.2011.49.6.363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Katsuta T, Inoue T, Nakagaki H, et al. Distinctions between pituicytoma and ordinary pilocytic astrocytoma. Case report. J Neurosurg 2003;98:404–6. 10.3171/jns.2003.98.2.0404 [DOI] [PubMed] [Google Scholar]
  • 19.Nishizawa S, Yokoyama T, Hinokuma K, et al. Pituitary astrocytoma: magnetic resonance and hormonal characteristics. Case illustration. J Neurosurg 1997;87:131. 10.3171/jns.1997.87.1.0131 [DOI] [PubMed] [Google Scholar]
  • 20.Hurley TR, D'Angelo CM, Clasen RA, et al. Magnetic resonance imaging and pathological analysis of a pituicytoma: case report. Neurosurgery 1994;35:314–7. 10.1227/00006123-199408000-00021 [DOI] [PubMed] [Google Scholar]
  • 21.Bell D, Chitnavis BP, Al-Sarraj S, et al. Pilocytic astrocytoma of the adult--clinical features, radiological features and management. Br J Neurosurg 2004;18:613–6. 10.1080/02688690400022896 [DOI] [PubMed] [Google Scholar]
  • 22.Ishkanian A, Laperriere NJ, Xu W, et al. Upfront observation versus radiation for adult pilocytic astrocytoma. Cancer 2011;117:4070–9. 10.1002/cncr.25988 [DOI] [PubMed] [Google Scholar]
  • 23.Collins VP, Jones DTW, Giannini C. Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol 2015;129:775–88. 10.1007/s00401-015-1410-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lee KJ, Marchan E, Peterson J, et al. Management and survival of adult patients with pilocytic astrocytoma in the National cancer database. World Neurosurg 2018;112:e881–7. 10.1016/j.wneu.2018.01.208 [DOI] [PubMed] [Google Scholar]
  • 25.Simonova G, Kozubikova P, Liscak R, et al. Leksell gamma knife treatment for pilocytic astrocytomas: long-term results. J Neurosurg Pediatr 2016;18:58–64. 10.3171/2015.10.PEDS14443 [DOI] [PubMed] [Google Scholar]
  • 26.Sorenson EJ, Silbert PL, Benarroch EE, et al. Transient amnestic syndrome after spontaneous haemorrhage into a hypothalamic pilocytic astrocytoma. J Neurol Neurosurg Psychiatry 1995;58:761–3. 10.1136/jnnp.58.6.761 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lyons MK. Pilocytic astrocytoma with spontaneous intracranial hemorrhages in an elderly adult. Clin Neurol Neurosurg 2007;109:76–80. 10.1016/j.clineuro.2006.03.002 [DOI] [PubMed] [Google Scholar]
  • 28.Sekula RF, Marchan EM, Quigley MR, et al. A case of an elderly adult presenting with obstructive hydrocephalus secondary to a rare hemorrhagic suprasellar pilocytic astrocytoma. Clin Neuropathol 2008;27:396–9. 10.5414/npp27396 [DOI] [PubMed] [Google Scholar]
  • 29.Sun S, Zhou H, Ding Z-Z, et al. Cerebellar pilocytic astrocytomas with spontaneous intratumoral hemorrhage in the elderly: a case report and review of the literature. Medicine 2018;97:e11329. 10.1097/MD.0000000000011329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lones MA, Verity MA. Fatal hemorrhage in a cerebral pilocytic astrocytoma-adult type. Acta Neuropathol 1991;81:688–90. 10.1007/BF00296382 [DOI] [PubMed] [Google Scholar]
  • 31.Bordes S, Werner C, Mathkour M, et al. Arterial supply of the thalamus: a comprehensive review. World Neurosurg 2020;137:310–8. 10.1016/j.wneu.2020.01.237 [DOI] [PubMed] [Google Scholar]
  • 32.Graffeo CS, Dietrich AR, Grobelny B, et al. A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors. Pituitary 2014;17:349–56. 10.1007/s11102-013-0508-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Komotar RJ, Starke RM, Raper DMS, et al. Endoscopic skull base surgery: a comprehensive comparison with open transcranial approaches. Br J Neurosurg 2012;26:637–48. 10.3109/02688697.2012.654837 [DOI] [PubMed] [Google Scholar]
  • 34.Rock AK, Dincer A, Carr MT, et al. Outcomes after craniotomy for resection of craniopharyngiomas in adults: analysis of the National surgical quality improvement program (NSQIP). J Neurooncol 2019;144:117–25. 10.1007/s11060-019-03209-9 [DOI] [PubMed] [Google Scholar]
  • 35.Jeswani S, Nuño M, Wu A, et al. Comparative analysis of outcomes following craniotomy and expanded endoscopic endonasal transsphenoidal resection of craniopharyngioma and related tumors: a single-institution study. J Neurosurg 2016;124:627–38. 10.3171/2015.3.JNS142254 [DOI] [PubMed] [Google Scholar]
  • 36.Komotar RJ, Starke RM, Raper DMS, et al. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg 2012;77:329–41. 10.1016/j.wneu.2011.07.011 [DOI] [PubMed] [Google Scholar]
  • 37.Wannemuehler TJ, Rubel KE, Hendricks BK, et al. Outcomes in transcranial microsurgery versus extended endoscopic endonasal approach for primary resection of adult craniopharyngiomas. Neurosurg Focus 2016;41:E6. 10.3171/2016.9.FOCUS16314 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES